London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca ...

We don't have anything new to report at this time," AstraZeneca's Chief Financial Officer Aradhana Sarin said during a media ...

Eric Le Berrigaud has given his Buy rating due to a combination of factors that reflect AstraZeneca’s strong performance and future potential. The company demonstrated robust growth in the third ...

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute ...

AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was described as cooperating “with an ongoing investigation”, the ...

For AZD5004, the company is already eyeing up opportunities to trial it alongside AstraZeneca’s approved SGLT2 inhibitor Farxiga and its oral PCSK9 inhibitor AZD0780, according to Sharon Barr ...

CEO Pascal Soriot said AstraZeneca complies with Chinese policies and works closely with authorities following the detention. As per a financial media company Yicai report, senior executives at ...

The company added that it will cooperate, if asked to do so. The move comes after authorities recently detained Eva Yin, a former AstraZeneca executive who is currently chief commercial officer ...

Two current and two former senior AstraZeneca Plc executives in the ... of laws around drug importation and data privacy, the company said. This is in addition to Leon Wang, the British drugmaker ...

The London-listed company now expects 2024 revenue and core earnings per share to grow by a high-teens percentage, from a ...